These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 18039642

  • 1. Predictors of new-onset decline in kidney function in a general middle-european population.
    Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1265-73. PubMed ID: 18039642
    [Abstract] [Full Text] [Related]

  • 2. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S.
    Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
    [Abstract] [Full Text] [Related]

  • 3. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K.
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [Abstract] [Full Text] [Related]

  • 4. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Jan; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.
    Viktorsdottir O, Palsson R, Andresdottir MB, Aspelund T, Gudnason V, Indridason OS.
    Nephrol Dial Transplant; 2005 Sep; 20(9):1799-807. PubMed ID: 15928100
    [Abstract] [Full Text] [Related]

  • 6. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 7. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A, Djurdjev O, Beaulieu M, Er L.
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [Abstract] [Full Text] [Related]

  • 8. [Prevalence of mild to moderate chronic kidney disease in the general population of Spain. Hortega study].
    Simal F, Martín Escudero JC, Bellido J, Arzua D, Mena FJ, González Melgosa I, Alvarez Hurtado AA, Tabuyo MB, Molina A.
    Nefrologia; 2004 Oct; 24(4):329-32, 334, 336-7. PubMed ID: 15455492
    [Abstract] [Full Text] [Related]

  • 9. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K.
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [Abstract] [Full Text] [Related]

  • 10. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, MMKD Study Group.
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for MDRD-GFR of less than 60 mL/min per 1.73 m2 in former kidney donors.
    Lee JH, Kim SC, Han DJ, Chang JW, Yang WS, Park SK, Lee SK, Park JS, Kim SB.
    Nephrology (Carlton); 2007 Dec; 12(6):600-6. PubMed ID: 17995588
    [Abstract] [Full Text] [Related]

  • 12. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M, Fernández-Reyes MJ, Sánchez R, Guerrero MT, Molina A, Rodríguez MA, Alvarez-Ude F.
    Nefrologia; 2012 May 14; 32(3):300-5. PubMed ID: 22508140
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence of chronic kidney disease in Chinese hospitalized adult patients: investigation of 13,383 cases].
    Wu XC, Liu BC, Wang YL, Wang B, Gao J, Zhang QJ, Zhu Y, Zhang XL, Yin LF.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 16; 87(38):2672-6. PubMed ID: 18167241
    [Abstract] [Full Text] [Related]

  • 14. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.
    Am J Kidney Dis; 2009 Mar 16; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [Abstract] [Full Text] [Related]

  • 15. [Comparison and agreement of the Cockcroft-Gault and MDRD equations to estimate glomerular filtration rate in diagnosis of occult chronic kidney disease].
    Buitrago F, Calvo JI, Gómez-Jiménez C, Cañón L, Robles NR, Angulo E.
    Nefrologia; 2008 Mar 16; 28(3):301-10. PubMed ID: 18590497
    [Abstract] [Full Text] [Related]

  • 16. [Predictors of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jul 16; 25(145):9-14. PubMed ID: 18839606
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group.
    Nephrol Dial Transplant; 2008 Dec 16; 23(12):3851-8. PubMed ID: 18641082
    [Abstract] [Full Text] [Related]

  • 18. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jun 16; 24(144):487-91. PubMed ID: 18702327
    [Abstract] [Full Text] [Related]

  • 19. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L.
    Am J Kidney Dis; 2006 Jun 16; 47(6):993-1003. PubMed ID: 16731294
    [Abstract] [Full Text] [Related]

  • 20. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN.
    Biol Blood Marrow Transplant; 2009 Oct 16; 15(10):1251-7. PubMed ID: 19747632
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.